Roxee Meds Catalog
Terbinafine
Medication catalog facts with explicit FDA-approval, off-label, source-limited, and safety context.
Veterinary professional?
Data freshness
Roxee is still reviewing source support for this medication profile.
Roxee has safety or ingredient evidence for this medication, but a regulatory product/application match is still pending.
openFDA reaction terms and case summaries are supporting evidence, not proof of causality.
Source timing details
-
Storefront facts:
Source Roxee
| Refreshed May 5, 2026, 10:05 AM UTC
The storefront fact projection used for browse cards and quick facts.
- openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
Evidence
Reviewed / Updated / Sources
Reviewed by: Not available
Last reviewed: April 15, 2026
Updated: April 15, 2026, 10:04 AM UTC
- Medication contraindications · safety_warning
- openFDA case USA-USFDACVM-2025-US-072174 · adverse_reaction
- FOI summary · document
- FOI summary · document
- FOI summary · document
Terbinafine
Drug type: Generic ingredient • Generic profile • Regulatory linkage incomplete
Species: Both
Approval status: Official document linked, regulatory match incomplete. An official source document is available, but Roxee has not linked this row to a confirmed FDA animal-drug application or product record yet.
Medication Snapshot
Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.
Terbinafine
For the treatment of otitis externa in dogs associated with susceptible strains of bacteria ( Staphylococcus pseudintermedius ) and yeast ( Malassezia pachydermatis ). CLARO™ is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast ( Malassezia pachydermatis ) and bacteria ( Staphylococcus pseudintermedius ). For the treatment of otitis externa associated with susceptible strains of yeast ( Malassezia pachydermatis ) and bacteria ( Staphylococcus pseudintermedius ) in dogs. Species commonly shown: Both.
Indications / Uses
For the treatment of otitis externa in dogs associated with susceptible strains of bacteria ( Staphylococcus pseudintermedius ) and yeast ( Malassezia pachydermatis ). CLARO™ is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast ( Malassezia pachydermatis ) and bacteria ( Staphylococcus pseudintermedius ). For the treatment of otitis externa associated with susceptible strains of yeast ( Malassezia pachydermatis ) and bacteria ( Staphylococcus pseudintermedius ) in dogs.
Warnings / Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Side Effects
Top reported reactions (openFDA): Lack of efficacy - NOS, Ear discharge, Vomiting, Loss of hearing, Deafness, Head shake - ear disorder.
FAQ
Related Conditions
Source Transparency
- Verified source: https://www.roxee.ai/meds/
- Verified source: https://animaldrugsatfda.fda.gov
- Verified source: https://api.fda.gov/animalandveterinary/event.json
- Verified source: https://www.roxee.ai/conditions/
- Verified source: https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17828
- Verified source: https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/18375
- Last refreshed: May 5, 2026, 10:05 a.m.
- Last verified: Apr 15, 2026, 10:04 a.m.
- Validation status: Incomplete
Add to My Pet's Meds
Choose a pet, confirm current or past, and optionally add reminder notes.
Sign in to save this medication to your pet profile.
Sign in to continuePet Owner Quick Guide
Start here first for the safest next-step summary before the deeper medication detail.
Used for:
For the treatment of otitis externa in dogs associated with susceptible strains of bacteria ( Staphylococcus pseudintermedius ) and yeast ( Malassezia pachydermatis ). CLARO™ is indicated for the treatment of otitis exte...
Dosing note:
Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.
What to watch for:
- For otic use in dogs only
- wobbly/unsteady walking (1 reports)
- Head tilt - ear disorder (1 reports)
- Head shake - ear disorder (1 reports)
When to call the vet:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
- Facial swelling or hives.
- Blood in vomit or stool.
Regulatory restrictions are shown in Vet View.
What to tell or ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Major cautions & emergency warning signs
Side effects to monitor:
- For otic use in dogs only
- wobbly/unsteady walking
- Head tilt - ear disorder
- Head shake - ear disorder
Most reported reactions:
- Unsteady walking (ataxia) (1 reports)
- Head tilt - ear disorder (1 reports)
- Head shake - ear disorder (1 reports)
Emergency warning signs:
- Repeated vomiting or diarrhea.
- Severe lethargy (hard to wake, very low energy).
- Collapse or fainting.
- Trouble breathing.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
Warnings / Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- https://animaldrugsatfda.fda.gov · safety_warning · Medication contraindications
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Grouped by Body System
Most Reported Reactions
| Reaction | Body system | Cases | Species | Serious cases |
|---|---|---|---|---|
| Neurologic | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Dog | 1 | |
| Other | 1 | Cat | 1 | |
| Other | 1 | Cat | 1 | |
| Skin & allergy | 1 | Dog | 1 | |
| Other | 1 | Dog | 1 |
Species coverage: Dog (20) Cat (12)
View detailed reaction table
| Reaction | Body system | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|---|
| Digestive | Dog | Non-serious | - | 1 | |
| Neurologic | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Skin & allergy | Dog | Non-serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Skin & allergy | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Digestive | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Behavior | Dog | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Digestive | Dog | Non-serious | - | 1 | |
| Behavior | Dog | Non-serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 | |
| Skin & allergy | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Digestive | Dog | Serious | - | 1 | |
| Other | Cat | Serious | - | 1 | |
| Other | Dog | Serious | - | 1 | |
| Other | Dog | Non-serious | - | 1 |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-072174
Documents
Owner handouts and official technical documents open on-page first, with the original source still one click away.
Owner handouts
0Official label / PI
0SPL
0FOI
6FOI Summary oA 200-848 Approved April 8, 2026.pdf
FOI · FOI summary
FOI Summary oA 200-829 Approved December 22, 2025.pdf
FOI · FOI summary
FOI Summary oN 141-598 Approved April 10 2025_ceg_ef.pdf
FOI · FOI summary
FOI Summary oA 200-719 Approved September 28, 2022.pdf
FOI · FOI summary
UCM465253.pdf
FOI · FOI summary
UCM436650.pdf
FOI · FOI summary
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/18375 · document · FOI summary
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17828 · document · FOI summary
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/16805 · document · FOI summary
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/12934 · document · FOI summary
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/931 · document · FOI summary
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/928 · document · FOI summary
Veterinary reference (advanced)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
-
Storefront facts:
Source Roxee
| Refreshed May 5, 2026, 10:05 AM UTC
The storefront fact projection used for browse cards and quick facts.
- openFDA reaction terms: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed May 5, 2026, 10:04 AM UTC
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 17030-001-10 | 17030 | - | |
| 17033-277-02 | 17033 | - | |
| 17033-277-20 | 17033 | - | |
| 17033-283-02 | 17033 | - | |
| 17033-283-20 | 17033 | - | |
| 51072-122-00 | 51072 | - | |
| 51072-122-01 | 51072 | - | |
| 51072-122-02 | 51072 | - | |
| 58198-0027-1 | 58198 | - | |
| 58198-0027-2 | 58198 | - | |
| 58198-0027-3 | 58198 | - | |
| 58198-0027-4 | 58198 | - | |
| 86032-057-01 | 86032 | - | |
| 86136-125-67 | 86136 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
FOI Summary oA 200-848 Approved April 8, 2026.pdf
• FOI summary • Official
• April 30, 2026
FDA FOI summary for application 200848
-
FOI Summary oA 200-829 Approved December 22, 2025.pdf
• FOI summary • Official
• Jan. 5, 2026
FDA FOI summary for application 200829
-
FOI Summary oN 141-598 Approved April 10 2025_ceg_ef.pdf
• FOI summary • Official
• June 3, 2025
FDA FOI summary for application 141598
-
FOI Summary oA 200-719 Approved September 28, 2022.pdf
• FOI summary • Official
• Oct. 3, 2022
FDA FOI summary for application 200719
-
UCM465253.pdf
• FOI summary • Official
• Aug. 3, 2021
FDA FOI summary for application 141440
-
UCM436650.pdf
• FOI summary • Official
• Aug. 11, 2020
FDA FOI summary for application 141437
Data Sources & Change Log
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-05-05)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-05-03)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-05-02)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-04-29)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-04-28)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-04-27)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-04-26)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-04-25)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-04-17)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-04-15)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-04-15)
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or o… (Clinical, 2026-04-11)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-21)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-20)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-19)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-17)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-16)
- monitoring: Monitor blood glucose and ketones, hydration status, appetite, and clinical response at regular intervals. (Clinical, 2026-04-15)
- side_effects: Top reported reactions (openFDA): Lack of efficacy - NOS, Ear discharge, Vomiting, Loss of hearing, Deafness, Head shake - ear disorder. (Clinical, 2026-04-11)
- side_effects updated 2026-05-05 10:05 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-05-05 10:05 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-05-05 10:05 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-05-03 10:05 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-05-03 10:05 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-05-03 10:05 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-05-02 10:05 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-05-02 10:05 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-05-02 10:05 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-04-30 10:09 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-04-29 10:05 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-04-29 10:05 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-04-29 10:05 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-04-28 10:05 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-04-28 10:05 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-04-28 10:05 by etl_backfill • Backfilled from existing medication fields
- side_effects updated 2026-04-27 10:05 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-04-27 10:05 by etl_backfill • Backfilled from existing medication fields
Usage
For the treatment of otitis externa in dogs associated with susceptible strains of bacteria ( Staphylococcus pseudintermedius ) and yeast ( Malassezia pachydermatis ). CLARO™ is indicated for the treatment of otitis externa in dogs associated with susceptible strains of yeast ( Malassezia pachydermatis ) and bacteria ( Staphylococcus pseudintermedius ). For the treatment of otitis externa associated with susceptible strains of yeast ( Malassezia pachydermatis ) and bacteria ( Staphylococcus pseudintermedius ) in dogs.
Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Top Reported Reactions (openFDA)
De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).
Showing top 5 for Digestive.
Showing top 5 for Skin & allergy.
Showing top 5 for Neurologic.
Showing top 5 for Behavior.
Show more (17)
Showing top 5 for Other.
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Terrier - Yorkshire, Female, 13 year, 6.12 kilogram • Drug: MSK, Unknown • Reactions: Partial lack of efficacy, Hair loss, Erythema, Papule, Excoriation… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-072174
- Serious AE: No
- Treated For AE: Yes
- Sex: Female
- Age: 13.00 Year
- Weight: 6.120 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Dog, ['Terrier (unspecified)', 'Dog (unknown)'], Female, 5 month, 5.987 kilogram • Drug: MSK, Unknown • Reactions: Hair loss, Bacterial skin infection NOS, Ringworm, Vomiting, Cough… • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-070191
- Serious AE: No
- Treated For AE: Yes
- Sex: Female
- Age: 5.00 Month
- Weight: 5.987 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.